NCI | Technology Transfer

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

The Netherlands
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Italy
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Ireland
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Hungary
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Greece
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Denmark
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Germany
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Czech Republic
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Switzerland
17753704.0
Filed on 2017-02-14

Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Read more about Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab

Belgium
17753704.0
Filed on 2017-02-14

Subscribe to NCI